✦ LIBER ✦

Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects

✍ Scribed by He, Yan-Ling; Ligueros-Saylan, Monica; Sunkara, Gangadhar; Sabo, Ron; Zhao, Charlie; Wang, Yibin; Campestrini, Joelle; Pommier, Françoise; Dole, Kiran; Marion, Alan; Dole, Willia P.; Howard, Dan

Book ID: 120249748
Publisher: Sage Publications
Year: 2008
Tongue: English
Weight: 566 KB
Volume: 48
Category: Article
ISSN: 0091-2700
DOI: 10.1177/0091270007307880

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of pharmacokinetic interactions of

Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

✍ S. VAIDYANATHAN; J. VALENCIA; C. KEMP; C. ZHAO; C-M. YEH; M-N. BIZOT; J. DENOUEL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB